Colgate-Palmolive: The Defensive Growth Case Is Delivering

Group 1 - Colgate-Palmolive Company (NYSE: CL) has underperformed since the last quarter of 2024, suggesting that the stock may have been overvalued following the market recovery in 2023 [1] - The company is viewed as a potential long-term investment opportunity, with a focus on understanding business model trends rather than short-term market fluctuations [1] Group 2 - The analysis emphasizes the importance of deep research in identifying growth investment opportunities while avoiding risky financial instruments [1]